Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-510,555
Closed -$5.71M 43
2023
Q1
$5.71M Hold
510,555
0.38% 41
2022
Q4
$4.3M Hold
510,555
0.27% 44
2022
Q3
$8.51M Hold
510,555
0.41% 41
2022
Q2
$7.51M Buy
510,555
+100,400
+24% +$2.07M 0.37% 44
2022
Q1
$10.2M Buy
410,155
+163,108
+66% +$4.21M 0.54% 32
2021
Q4
$7.92M Hold
247,047
0.38% 35
2021
Q3
$8.89M Buy
247,047
+60,000
+32% +$2.36M 0.46% 30
2021
Q2
$8.25M Hold
187,047
0.37% 41
2021
Q1
$8.56M Hold
187,047
0.35% 36
2020
Q4
$12.9M Buy
+187,047
New +$9.16M 0.55% 30

Other funds holding LUNG

Novo Holdings A/S's LUNG Position: Q2 2023 in Review

Novo Holdings A/S sold out of Pulmonx (LUNG) in Q2 2023, closing a stake of 510,555 shares — an estimated $5.71M sold.

Novo Holdings A/S first reported a position in LUNG in Q4 2020 and held it in 10 quarters. The position peaked at $12.9M in Q4 2020. 115 funds tracked by Wall St. Rank hold LUNG as of Q2 2023.

  • Novo Holdings A/S reported no remaining Pulmonx position as of Q2 2023 after selling out during the quarter.
  • Novo Holdings A/S sold 510,555 Pulmonx shares in Q2 2023, an estimated $5.71M.
  • Novo Holdings A/S first reported a position in Pulmonx in Q4 2020 and held it in 10 quarters.
  • Novo Holdings A/S's Pulmonx position peaked at $12.9M in Q4 2020.
  • 115 funds tracked by Wall St. Rank held Pulmonx as of Q2 2023.

Based on Novo Holdings A/S's 13F filing for Q2 2023, filed 14 Aug 2023.